招商局中國基金(00133.HK)以196萬人幣悉售江蘇華爾7.5%股權
招商局中國基金(00133.HK)公布,公司的全資附屬天正同意轉讓所持有的全部江蘇華爾的7.5%股權,代價為196萬元人民幣。天正已於昨日(28日)收到該筆代價價款。
集團指,由於受2018年光伏新政限制光伏電站建設規模和縮減電價補貼的影響,江蘇華爾的客戶相繼減產,進而減少了對單晶矽電池片和石英坩堝的需求。同時,江蘇華爾因被拖欠賬款而導致資金周轉減慢,而融資成本依然高企,正常生產經營受此影響較大,預期江蘇華爾未來難以扭虧。為避免蒙受更多損失,公司認為儘早退出此項投資對公司及其股東有利。(ek/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.